Histopathological findings in grade IV capsular contracture clinically diagnosed at the Hospital General de México
DOI:
https://doi.org/10.18203/2320-6012.ijrms20262170Keywords:
Capsular contracture, Baker grade IV, Capsulectomy, Breast implant, Histopathology, Synovial metaplasia, FibrosisAbstract
Background: To describe the histopathological findings in capsular tissue obtained from female patients with grade IV capsular contracture (Baker classification) who underwent explantation with capsulectomy at the Hospital General de México.
Methods: An observational, retrospective and descriptive study was conducted at the Plastic and Reconstructive Surgery Service of the Hospital General de México "Dr. Eduardo Liceaga." Female patients with breast implants who were clinically diagnosed with grade IV capsular contracture (Baker) between June 2023 and June 2026 were included. All patients underwent explantation with capsulectomy and capsular specimens were sent for histopathological analysis to the hospital's Pathology Department. Pre-surgical variables (age, implant longevity, number of previous exchanges), intraoperative variables (implant integrity, placement plane, type of capsulectomy) and histopathological findings were analyzed. Descriptive statistics were used, with absolute frequencies and percentages for qualitative variables and means and standard deviations for quantitative variables.
Results: A total of 50 female patients were included, with a mean age of 49.1±10.1 years (range: 30–70 years). The mean implant longevity was 12.4 years and 86% had no previous implant exchange. The implant was intact in 92% of cases, the retro glandular plane was identified in 78% and total capsulectomy was performed in 88%. Fibrosis was present in 100% of specimens, predominantly moderate (35, 70%) and extensive/marked (11, 22%). Synovial metaplasia was identified in 33 (66%) of cases. Chronic inflammation was present in 35 (70%) of cases, with nonspecific/mild inflammation being the most prevalent subtype (19, 38%), followed by granulomatous foreign body-type inflammation (10, 20%) and xanthomatous inflammation (6, 12%). Dystrophic calcification was found in 8 (16%), stromal hyalinization in 4 (8%), hemorrhage in 3 (6%), bacterial colonies in 1 (2%) and apocrine metaplasia in 2 (4%). Residual mammary parenchymal findings were identified in 7 (14%) of cases. All 50 (100%) specimens were negative for malignancy.
Conclusions: The histopathological analysis of periprosthetic capsules in patients with grade IV capsular contracture demonstrates a consistent pattern dominated by fibrosis, present universally and synovial metaplasia, identified in two-thirds of cases. The presence of chronic inflammation in the majority of patients and dystrophic calcification in a relevant subset reflects a sustained foreign body response. No specimen showed evidence of malignancy. These findings provide a histopathological baseline for grade IV capsular contracture in a Mexican tertiary care center.
References
Campiglio G. International Society of Aesthetic Plastic Surgery (ISAPS) International survey on aesthetic/cosmetic procedures performed in 2022. 2023
Headon H, Kasem A, Mokbel K. Capsular Contracture after Breast Augmentation: An Update for Clinical Practice. Arch Plast Surg. 2015;42(5):532-43.
Baker JL. Classification of spherical contractures. Aesthetic Breast Symposium, Scottsdale, AZ. 1975.
Hu H, Jacombs A, Vickery K, Merten SL, Pennington DG, Deva AK. Chronic biofilm infection in breast implants is associated with an increased T-cell lymphocytic infiltrate: implications for breast implant-associated lymphoma. Plast Reconstr Surg. 2015;135(2):319-29.
Swanson E. Prospective outcome study of 225 cases of breast augmentation. Plast Reconstr Surg. 2013;131(5):1158-66.
Barone FE, Perry L, Keller T, Maxwell GP. The biodynamics of liquid and gel saline implants in subpectoral, subfascial and retromammary planes. Plast Reconstr Surg. 1992;90(5):804-11.
Shah Z, Lehman JA Jr, Tan J. Does infection play a role in breast capsular contracture. Plast Reconstr Surg. 1981;68(1):34-42.
Moyer HR, Hart AM, Yeager J, Losken A. Histological analysis of periprothesic capsular tissue from shape-stable breast implants. Aesthet Surg J. 2014;34(4):554-61.
Embrey M, Adams EE, Cunningham B, Peters W, Young VL, Carlo GL. A review of the literature on the etiology of capsular contracture and a pilot study to determine the outcome of capsular contracture interventions. Aesthetic Plast Surg. 1999;23(3):197-206.
Pirro O, Mestak O, Vindigni V. Comparison of patient-reported outcomes after implant versus autologous tissue breast reconstruction using the BREAST-Q. Plast Reconstr Surg Glob Open. 2017;5(1):1217.
Hester TR Jr, Tebbetts JB, Maxwell GP. The polyurethane-covered mammary prosthesis: facts and fiction (II): a look back and a "peek" ahead. Clin Plast Surg. 2001;28(3):579-86.
Bui JM, Perry T, Ren CD, Nofrey B, Teitelbaum S, Van Epps DE. Histological characterization of human breast implant capsules. Aesthetic Plast Surg. 2015;39(3):306-15.
Spear SL, Murphy DK. Allergan Silicone Breast Implant U.S. Core Clinical Study Group. Natrelle round silicone breast implants: Core Study results at 10 years. Plast Reconstr Surg. 2014;133(6):1354-61.
Deva AK, Adams WP Jr, Vickery K. The role of bacterial biofilms in device-associated infection. Plast Reconstr Surg. 2013;132(5):1319-28.
Adams WP Jr, Rios JL, Smith SJ. Enhancing patient outcomes in aesthetic and reconstructive breast surgery using triple antibiotic breast irrigation: six-year prospective clinical study. Plast Reconstr Surg. 2006;118(7):46-52.
Clemens MW, Brody GS, Mahabir RC, Miranda RN. How to diagnose and treat breast implant-associated anaplastic large cell lymphoma. Plast Reconstr Surg. 2018;141(4):586-99.